Insider Trading History of Laumas Sandeep

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Laumas Sandeep since 2018. This trader's CIK number is 1721664. At the time of last reporting, Laumas Sandeep was the CFO and CBO of Instil Bio, Inc.. (stock ticker symbol TIL). Also see all insider trading activities at Instil Bio, Inc..

Note that in the past Laumas Sandeep also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at 9 Meters Biopharma, Inc. (INNT) by Laumas Sandeep

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 INNT 10,000 $12,714 0 $0 0 $0
2018 INNT 7,750 $24,962 0 $0 0 $0

Yearly summary of insider trading at Instil Bio, Inc. (TIL) by Laumas Sandeep

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 TIL 0 $0 30,000 $703,800 30,000 $364,200


Insider trading activities at 2 companies by Laumas Sandeep:

1. 9 Meters Biopharma, Inc. (INNT)

2. Instil Bio, Inc. (TIL)

Table 1. Insider trading of 9 Meters Biopharma, Inc. (INNT) by Laumas Sandeep

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-06-28 INNT Buy 4,000 1.15 4,600
2019-06-13 INNT Buy 1,000 1.22 1,215
2019-05-22 INNT Buy 5,000 1.38 6,899
2018-11-30 INNT Buy 3,000 2.63 7,890
2018-11-29 INNT Buy 3,000 2.56 7,665
2018-09-07 INNT Buy 500 6.10 3,050
2018-08-30 INNT Buy 500 5.24 2,620
2018-08-28 INNT Buy 750 4.98 3,737

Table 2. Insider trading of Instil Bio, Inc. (TIL) by Laumas Sandeep

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-09-10 TIL Option Ex 30,000 12.14 364,200
2025-09-10 TIL Sale 30,000 23.46 703,800

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Laumas Sandeep (CFO and CBO of Instil Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.